James O Armitage - Net Worth and Insider Trading
James O Armitage Net Worth
The estimated net worth of James O Armitage is at least $152,480 dollars as of 2024-11-10. James O Armitage is the Director of Tesaro Inc and owns about 1,500 shares of Tesaro Inc (TSRO) stock worth over $112,440. James O Armitage is also the Director of Cardiff Oncology Inc and owns about 13,000 shares of Cardiff Oncology Inc (CRDF) stock worth over $40,040. Details can be seen in James O Armitage's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James O Armitage has not made any transactions after 2022-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James O Armitage
James O Armitage Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James O Armitage owns 2 companies in total, including Cardiff Oncology Inc (CRDF) , and Tesaro Inc (TSRO) .
Click here to see the complete history of James O Armitage’s form 4 insider trades.
Insider Ownership Summary of James O Armitage
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRDF | Cardiff Oncology Inc | 2022-09-16 | director |
| TSRO | Tesaro Inc | 2019-01-22 | director |
James O Armitage Latest Holdings Summary
James O Armitage currently owns a total of 2 stocks. Among these stocks, James O Armitage owns 1,500 shares of Tesaro Inc (TSRO) as of September 18, 2017, with a value of $112,440 and a weighting of 73.74%. James O Armitage also owns 13,000 shares of Cardiff Oncology Inc (CRDF) as of September 16, 2022, with a value of $40,040 and a weighting of 26.26%.
Latest Holdings of James O Armitage
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSRO | Tesaro Inc | 2017-09-18 | 1,500 | 74.96 | 112,440 |
| CRDF | Cardiff Oncology Inc | 2022-09-16 | 13,000 | 3.08 | 40,040 |
Holding Weightings of James O Armitage
James O Armitage Form 4 Trading Tracker
According to the SEC Form 4 filings, James O Armitage has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the sale of 10,000 shares on September 18, 2017, which brought James O Armitage around $1 Million.
According to the SEC Form 4 filings, James O Armitage has made a total of 3 transactions in Cardiff Oncology Inc (CRDF) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Cardiff Oncology Inc is the acquisition of 13,000 shares on September 16, 2022, which cost James O Armitage around $20,280.
Insider Trading History of James O Armitage
- 1
James O Armitage Trading Performance
GuruFocus tracks the stock performance after each of James O Armitage's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James O Armitage is 62.7%. GuruFocus also compares James O Armitage's trading performance to market benchmark return within the same time period. The performance of stocks bought by James O Armitage within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James O Armitage's insider trading performs compared to the benchmark.
Performance of James O Armitage
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.68 | | | | | |
| Relative Return to S&P 500(%) | 1.74 | | | | | |
James O Armitage Ownership Network
Ownership Network List of James O Armitage
Ownership Network Relation of James O Armitage
James O Armitage Owned Company Details
What does Cardiff Oncology Inc do?
Who are the key executives at Cardiff Oncology Inc?
James O Armitage is the director of Cardiff Oncology Inc. Other key executives at Cardiff Oncology Inc include Chief Medical Officer Fairooz Kabbinavar , Chief Scientific Officer Mark Erlander , and Chief Financial Officer James E. Levine .
Cardiff Oncology Inc (CRDF) Insider Trades Summary
Over the past 18 months, James O Armitage made no insider transaction in Cardiff Oncology Inc (CRDF). Other recent insider transactions involving Cardiff Oncology Inc (CRDF) include a net purchase of 52,950 shares made by Gary W Pace ,
In summary, during the past 3 months, insiders sold 0 shares of Cardiff Oncology Inc (CRDF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiff Oncology Inc (CRDF) were sold and 52,950 shares were bought by its insiders, resulting in a net purchase of 52,950 shares.
Cardiff Oncology Inc (CRDF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cardiff Oncology Inc Insider Transactions
James O Armitage Mailing Address
Above is the net worth, insider trading, and ownership report for James O Armitage. You might contact James O Armitage via mailing address: C/o Tesaro, Inc., 1000 Winter St., Suite 3300, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
